Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$914.37 8.99 (0.99%) as of 4:30 Mon 7/1


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 874.67(B)
Last Volume: 2,545,641 Avg Vol: 3,268,697
52 Week Range: $434.7 - $909.04
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 1,520,577 2,391,327 3,771,329 6,318,238
Total Sell Value $1,284,658,855 $1,892,909,435 $2,147,483,647 $2,147,483,647
Total People Sold 3 3 4 6
Total Sell Transactions 18 31 50 93
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 1436
  Page 52 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lechleiter John C Chairman, President and CEO   •       •      –    2015-04-28 4 OE $56.18 $3,932,600 D/D 70,000 732,416     -
   Ricks David A SVP and Pres, Lilly Bio-Meds   •       –      –    2015-03-31 5 GD $0.00 $0 D/D 183 61,017     -
   Alvarez Ralph Director   –       •      –    2015-03-31 4 A $71.07 $9,950 D/D 140 27,179     -
   Lilly Endowment Inc 10% Owner   –       –       •   2015-03-30 4 S $73.94 $13,308,660 D/D (180,000) 131,035,804     -
   Lilly Endowment Inc 10% Owner   –       –       •   2015-03-23 4 S $76.95 $14,624,034 D/D (190,000) 131,215,804     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2015-03-12 4 GD $0.00 $0 D/D 1,580 654,201     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2015-03-11 4 GD $0.00 $0 D/D 3,675 655,781     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2015-03-10 4 GD $0.00 $0 D/D 10,654 659,456     -
   Fry Stephen F SVP, HR & Diversity   •       –      –    2015-03-09 4 S $69.27 $277,080 D/D (4,000) 59,690     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2015-03-04 5 GD $0.00 $0 D/D 140 62,588     -
   Alvarez Ralph Director   –       •      –    2015-02-27 4 A $71.56 $9,947 D/D 139 26,851     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2015-02-11 4 D $70.50 $568,583 D/D (8,065) 87,728     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2015-02-11 4 OE $56.18 $507,642 D/D 9,036 95,793     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2015-02-10 4 GA $0.00 $0 I/I 55,061 333,324     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2015-02-10 4 GD $0.00 $0 D/D 55,061 7,800     -
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2015-02-05 4 S $71.03 $26,565 D/D (374) 4,046     -
   Ricks David A SVP and Pres, Lilly Bio-Meds   •       –      –    2015-02-04 4 AS $69.99 $220,259 D/D (3,147) 60,138     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2015-02-04 4 AS $70.00 $372,120 D/D (5,316) 55,061     -
   Lundberg Jan M EVP,Science&Tech and Pres. LRL   •       –      –    2015-02-04 4 S $70.08 $776,837 D/D (11,085) 77,420     -
   Lundberg Jan M EVP,Science&Tech and Pres. LRL   •       –      –    2015-02-03 4 S $70.72 $5,071,402 D/D (71,711) 88,505     -
   Lundberg Jan M EVP,Science&Tech and Pres. LRL   •       –      –    2015-02-02 4 S $70.87 $3,543,500 D/D (50,000) 160,216     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2015-02-02 4 AS $71.84 $723,285 D/D (10,068) 60,377     -
   Ricks David A SVP and Pres, Lilly Bio-Meds   •       –      –    2015-02-02 4 AS $71.51 $341,031 D/D (4,769) 63,285     -
   Peterson Barton R Sr. VP, Corp. Affairs & Comm.   •       –      –    2015-02-01 4 D $72.00 $236,880 D/D (3,290) 79,405     -
   Peterson Barton R Sr. VP, Corp. Affairs & Comm.   •       –      –    2015-02-01 4 OE $0.00 $0 D/D 6,995 82,695     -
  1436 Records found
  Previous  50  51  52  53  54  55  56  57  58   
  Page 52 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us